Secondary Infections in Febrile Neutropenia in Hematological Malignancies: More Than Another Febrile Neutropenic Episode

Creative Commons License

Demirel A., Tabak F., Ar M. C., Mete B., Ongoren S., Yemisen M., ...Daha Fazla

TURKISH JOURNAL OF HEMATOLOGY, cilt.32, sa.3, ss.243-250, 2015 (SCI-Expanded, Scopus, TRDizin) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 32 Sayı: 3
  • Basım Tarihi: 2015
  • Doi Numarası: 10.4274/tjh.2013.0422
  • Dergi Adı: TURKISH JOURNAL OF HEMATOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.243-250
  • Anahtar Kelimeler: Secondary infection, Febrile neutropenia, Hematological malignancy, Mortality, Leukemia, Lymphoma, PIPERACILLIN-TAZOBACTAM, EMPIRICAL-TREATMENT, RISK-FACTORS, CANCER, EPIDEMIOLOGY, MONOTHERAPY, MORTALITY, CEFEPIME, IMIPENEM, THERAPY
  • Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
  • İstanbul Üniversitesi-Cerrahpaşa Adresli: Evet

Özet

Objective: Febrile neutropenic episodes (FNEs) are among the major causes of mortality in patients with hematological malignancies. Secondary infections develop either during the empirical antibiotic therapy or 1 week after cessation of therapy for a FNE. The aim of this study was to investigate the risk factors associated with secondary infections in febrile neutropenic patients.